scispace - formally typeset
Y

Yong Ku Kim

Researcher at Korea University

Publications -  156
Citations -  4027

Yong Ku Kim is an academic researcher from Korea University. The author has contributed to research in topics: Major depressive disorder & Panic disorder. The author has an hindex of 27, co-authored 156 publications receiving 2787 citations.

Papers
More filters

Research report Kynurenine pathway in major depression: Evidence of impaired neuroprotection

TL;DR: The results suggested that the reduction in neuroprotective markers, which indicated an impaired neuroprotection, might play an important role in pathophysiology of major depression.
Journal ArticleDOI

Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression.

TL;DR: This review focuses on the interaction between stress, the autonomic nervous system and the immune system which can cause imbalances in the kynurenine pathway, which may ultimately lead to major depressive disorder.
Journal ArticleDOI

Differentiating between bipolar and unipolar depression in functional and structural MRI studies

TL;DR: Structural and functional magnetic resonance imaging studies that directly compare UD and BD depression based on neuroimaging modalities including functional MRI studies on regional brain activation or functional connectivity, structural MRI on gray or white matter morphology, and pattern classification analyses using a machine learning approach are reviewed.
Journal ArticleDOI

The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments.

TL;DR: The microbiota–gut–brain axis might provide novel targets for prevention and treatment of neuropsychiatric disorders, however, further studies are required to substantiate the clinical use of probiotics, prebiotics and FMT.
Journal ArticleDOI

The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease

TL;DR: Data demonstrating the role of CREB-BDNF signaling pathway in cognitive status and mediation of Aβ toxicity in AD is summarized and the developing intervention methods for improvement of cognitive decline in AD based on targeting ofCREB- BDNF pathway are focused on.